Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Get Free Report) has received a consensus recommendation of “Buy” from the six analysts that are presently covering the stock, Marketbeat.com reports. Six research analysts have rated the stock with a buy recommendation. The average twelve-month price objective among analysts that have covered the stock in the last year […]
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives $20.25 Average Price Target from Analysts themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright reissued their buy rating on shares of Rani Therapeutics (NASDAQ:RANI – Free Report) in a research report sent to investors on Friday morning, Benzinga reports. They currently have a $20.00 price objective on the stock. RANI has been the subject of a number of other reports. Bank of America dropped their price objective […]